SEER INC. - CLASS A COMMON STOCK

Seer to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2021

01 Feb 2022 16:05:00 By Nasdaq GlobeNewswire

Updated: Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Centers of Excellence Program

10 Jan 2022 14:58:08 By Nasdaq GlobeNewswire

Seer, Discovery Life Sciences and SCIEX Announce First-Of-Its-Kind Proteogenomics Consortium for Large-Scale Studies

10 Jan 2022 09:00:00 By Nasdaq GlobeNewswire

Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Centers of Excellence Program

10 Jan 2022 08:00:04 By Nasdaq GlobeNewswire

Seer to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference

29 Dec 2021 08:05:00 By Nasdaq GlobeNewswire

Seer Appoints Meeta Gulyani to its Board of Directors

29 Nov 2021 16:05:00 By Nasdaq GlobeNewswire

Seer to Participate in the Piper Sandler Virtual Healthcare Conference

22 Nov 2021 08:05:00 By Nasdaq GlobeNewswire

Seer Reports Third Quarter 2021 Financial Results

09 Nov 2021 16:05:01 By Nasdaq GlobeNewswire

Seer Appoints Rachel Haurwitz, Ph.D., to its Board of Directors

08 Nov 2021 16:05:00 By Nasdaq GlobeNewswire

Seer to Report Third Quarter Financial Results on November 9, 2021

12 Oct 2021 16:05:00 By Nasdaq GlobeNewswire

Seer Reports Second Quarter 2021 Financial Results

12 Aug 2021 16:06:00 By Nasdaq GlobeNewswire

Seer Bio Partners with Enlight Medical to Commercialize the Proteograph™ Product Suite in China

12 Aug 2021 16:01:00 By Nasdaq GlobeNewswire

Seer to Report Second Quarter Financial Results on August 12, 2021

13 Jul 2021 16:05:00 By Nasdaq GlobeNewswire

Seer Reports First Quarter 2021 Financial Results

10 May 2021 16:05:00 By Nasdaq GlobeNewswire

Seer to Present at the BofA Securities 2021 Healthcare Conference

04 May 2021 16:05:01 By Nasdaq GlobeNewswire

Seer to Report First Quarter Financial Results on May 10, 2021

12 Apr 2021 16:05:00 By Nasdaq GlobeNewswire

Seer Reports Fourth Quarter and Full Year 2020 Financial Results and Fuels Commercial Progress in 2021 with New Collaborators and Partnerships

29 Mar 2021 16:05:00 By Nasdaq GlobeNewswire

Seer and SCIEX Sign Commercial Agreement to Offer End-to-End Unbiased Proteomics Solutions

29 Mar 2021 16:05:00 By Nasdaq GlobeNewswire

Seer to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021

01 Mar 2021 08:05:00 By Nasdaq GlobeNewswire

Seer to Present at the Cowen 41st Annual Healthcare Conference

24 Feb 2021 16:05:01 By Nasdaq GlobeNewswire